Legal & General Group Plc Purchases 13,350 Shares of Healthequity Inc (HQY)

Legal & General Group Plc boosted its position in Healthequity Inc (NASDAQ:HQY) by 15.2% in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 100,891 shares of the company’s stock after buying an additional 13,350 shares during the quarter. Legal & General Group Plc owned approximately 0.17% of Healthequity worth $5,100,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other large investors have also recently added to or reduced their stakes in HQY. Janus Henderson Group PLC boosted its holdings in shares of Healthequity by 627.9% in the second quarter. Janus Henderson Group PLC now owns 2,113,030 shares of the company’s stock worth $105,292,000 after acquiring an additional 1,822,732 shares during the period. Eagle Asset Management Inc. bought a new position in shares of Healthequity in the third quarter worth $36,875,000. FMR LLC boosted its holdings in shares of Healthequity by 45.6% in the second quarter. FMR LLC now owns 2,235,150 shares of the company’s stock worth $111,378,000 after acquiring an additional 699,728 shares during the period. TimesSquare Capital Management LLC bought a new position in shares of Healthequity in the second quarter worth $25,822,000. Finally, BlackRock Inc. boosted its holdings in shares of Healthequity by 4.3% in the second quarter. BlackRock Inc. now owns 5,831,014 shares of the company’s stock worth $290,559,000 after acquiring an additional 241,061 shares during the period. 98.60% of the stock is owned by institutional investors and hedge funds.

In related news, VP Darcy G. Mott sold 9,500 shares of Healthequity stock in a transaction on Wednesday, September 20th. The stock was sold at an average price of $46.79, for a total transaction of $444,505.00. Following the completion of the sale, the vice president now owns 87,500 shares of the company’s stock, valued at $4,094,125. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, Director Frank Medici sold 419,504 shares of Healthequity stock in a transaction on Monday, November 6th. The shares were sold at an average price of $52.97, for a total value of $22,221,126.88. Following the sale, the director now directly owns 6,381 shares of the company’s stock, valued at approximately $338,001.57. The disclosure for this sale can be found here. Insiders have sold 1,761,117 shares of company stock valued at $91,904,676 in the last three months. 29.00% of the stock is owned by corporate insiders.

Shares of Healthequity Inc (HQY) opened at $46.14 on Tuesday. The stock has a market capitalization of $2,784.28, a price-to-earnings ratio of 65.56, a P/E/G ratio of 1.90 and a beta of 1.74. Healthequity Inc has a 52 week low of $37.62 and a 52 week high of $55.31.

Healthequity (NASDAQ:HQY) last posted its quarterly earnings data on Tuesday, December 5th. The company reported $0.17 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $0.13 by $0.04. The company had revenue of $56.80 million during the quarter, compared to analyst estimates of $55.27 million. Healthequity had a return on equity of 14.47% and a net margin of 21.08%. The firm’s quarterly revenue was up 31.0% on a year-over-year basis. During the same quarter last year, the company earned $0.10 earnings per share. equities analysts anticipate that Healthequity Inc will post 0.71 earnings per share for the current fiscal year.

HQY has been the subject of a number of analyst reports. Zacks Investment Research raised Healthequity from a “hold” rating to a “buy” rating and set a $60.00 price target for the company in a report on Wednesday, November 8th. Oppenheimer reaffirmed a “buy” rating and issued a $61.00 price target on shares of Healthequity in a report on Wednesday, September 6th. Cantor Fitzgerald reaffirmed a “buy” rating and issued a $56.00 price target on shares of Healthequity in a report on Tuesday, September 5th. Chardan Capital raised their price target on Healthequity from $58.00 to $62.00 and gave the stock a “buy” rating in a report on Wednesday, December 6th. Finally, BidaskClub raised Healthequity from a “sell” rating to a “hold” rating in a report on Thursday, September 28th. One investment analyst has rated the stock with a sell rating, two have given a hold rating and eight have given a buy rating to the stock. The company presently has an average rating of “Buy” and a consensus price target of $58.33.

TRADEMARK VIOLATION WARNING: “Legal & General Group Plc Purchases 13,350 Shares of Healthequity Inc (HQY)” was posted by Sports Perspectives and is owned by of Sports Perspectives. If you are viewing this news story on another domain, it was stolen and republished in violation of US and international copyright laws. The correct version of this news story can be accessed at https://sportsperspectives.com/2017/12/19/legal-general-group-plc-purchases-13350-shares-of-healthequity-inc-hqy.html.

Healthequity Company Profile

HealthEquity, Inc provides a range of solutions for managing healthcare accounts (Health Savings Accounts (HSAs), Health Reimbursement Arrangements (HRAs) and Flexible Spending Accounts (FSAs)) for health plans, insurance companies and third-party administrators. The Company is engaged in technology-enabled services platforms that allow consumers to make healthcare saving and spending decisions.

Want to see what other hedge funds are holding HQY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Healthequity Inc (NASDAQ:HQY).

Institutional Ownership by Quarter for Healthequity (NASDAQ:HQY)

Receive News & Ratings for Healthequity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthequity and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply